Skip to main content

Cardiol Therapeutics Inc.

CRDL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001702123

No open-market purchases or sales by Cardiol Therapeutics Inc. insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $31.3M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Cardiol Therapeutics Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of CRDL: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders4143+2
Shares4.97M7.49M+2.52M (+50.7%)
Value$9.85M$9.60M−$253.1K (−2.6%)

New holders (13)

Institutions that held Cardiol Therapeutics Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to CRDL in Q4 2024
InstitutionSharesValue% of portfolio
PVG Asset Management Corp487,295$623.7K2.95%
Envestnet Asset Management Inc309,684$398.1K0.00%
Atria Investments LLC135,891$173.9K0.00%
Virtu Financial LLC48,031$61.0K0.00%
Cetera Investment Advisers43,547$55.9K0.00%
Jones Financial Companies LLLP19,847$25.4K0.00%
Marshall Wace, LLP13,193$16.9K0.00%
Evelyn Partners Investment Management LLP10,000$12.9K0.00%
New Wave Wealth Advisors LLC1,000$1.28K0.00%
SBI Securities Co., Ltd.275$3520.00%
Wingate Wealth Advisors, Inc.85$1090.00%
MAI Capital Management25$320.00%
Toronto Dominion Bank1$10.00%

Sold out (11)

Institutions that held Cardiol Therapeutics Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of CRDL in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Foundations Investment Advisors, LLC161,950$320.7K
UBS Asset Management Americas Inc55,000$108.9K
Two Sigma Investments, LP24,666$48.8K
Two Sigma Securities, LLC16,916$33.5K
Jane Street Group, LLC14,759$29.4K
TownSquare Capital, LLC13,745$27.2K
JPMorgan Chase & Co2,500$4.95K
Rise Advisors, LLC1,000$1.98K
Central Trust Co400$792
Huntington National Bank241$477
Stone House Investment Management, LLC50$99